Literature DB >> 17210630

Hippocampal volume and subcortical white matter lesions in late life depression: comparison of early and late onset depression.

Joost Janssen1, Hilleke E Hulshoff Pol, Frank-Erik de Leeuw, Hugo G Schnack, Indrag K Lampe, Rob M Kok, Rene S Kahn, Thea J Heeren.   

Abstract

BACKGROUND: Reduced hippocampal volume and increased prevalence of subcortical white matter lesions are associated with both recurrent early onset depression (EOD) and late onset depression (LOD). It is not clear whether these two factors differentially affect the age of onset of first depression. Therefore, we wished to investigate the relationship between age of first depression onset and hippocampal volume, with adjustment for subcortical white matter lesions.
METHODS: MRI brain scans were used to compare hippocampal volumes and white matter lesions between age matched female patients (>60 years) with recurrent EOD and LOD and healthy controls.
RESULTS: When comparing the three groups and adjusting for age, the Mini-Mental State Examination score, total brain volume and total hippocampal volume were significantly smaller in patients with EOD compared with controls (5.6 vs 6.1 ml; p = 0.04). The prevalence of larger subcortical white matter lesions was higher in patients with LOD compared with patients with EOD (47% vs 8%; p = 0.002). Patients with LOD did not differ in hippocampal volume from patients with EOD or from controls.
CONCLUSIONS: In late life depression, age of first depression onset may distinguish between different independent neuropathological mechanisms. A small hippocampus volume may be a neuroanatomical marker of EOD depression and larger subcortical white matter lesions could be an intermediate between cerebrovascular disease and LOD.

Entities:  

Mesh:

Year:  2007        PMID: 17210630      PMCID: PMC2077968          DOI: 10.1136/jnnp.2006.098087

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

1.  Autonomous neurobiological pathways to late-life major depressive disorder: clinical and pathophysiological implications.

Authors:  Anand Kumar; Jim Mintz; Warren Bilker; Gary Gottlieb
Journal:  Neuropsychopharmacology       Date:  2002-02       Impact factor: 7.853

2.  Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression.

Authors:  Ian Hickie; Sharon Naismith; Philip B Ward; Keelin Turner; Elizabeth Scott; Philip Mitchell; Kay Wilhelm; Gordon Parker
Journal:  Br J Psychiatry       Date:  2005-03       Impact factor: 9.319

Review 3.  Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.

Authors:  R M Sapolsky
Journal:  Arch Gen Psychiatry       Date:  2000-10

4.  Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss.

Authors:  J J Kril; S Patel; A J Harding; G M Halliday
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

5.  Depression with late onset is associated with right frontal lobe atrophy.

Authors:  O P Almeida; E J Burton; N Ferrier; I G McKeith; J T O'Brien
Journal:  Psychol Med       Date:  2003-05       Impact factor: 7.723

6.  Subcortical lesion severity and orbitofrontal cortex volume in geriatric depression.

Authors:  Shwu-Hua Lee; Martha E Payne; David C Steffens; Douglas R McQuoid; Te-Jen Lai; James M Provenzale; K Ranga Rama Krishnan
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

7.  Course of illness, hippocampal function, and hippocampal volume in major depression.

Authors:  Glenda M MacQueen; Stephanie Campbell; Bruce S McEwen; Kathryn Macdonald; Shigeko Amano; Russell T Joffe; Claude Nahmias; L Trevor Young
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-24       Impact factor: 11.205

8.  Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression.

Authors:  K Ranga Rama Krishnan; Warren D Taylor; Douglas R McQuoid; James R MacFall; Martha E Payne; James M Provenzale; David C Steffens
Journal:  Biol Psychiatry       Date:  2004-02-15       Impact factor: 13.382

9.  White matter lesions and hippocampal atrophy in Alzheimer's disease.

Authors:  Frank-Erik de Leeuw; Frederik Barkhof; Philip Scheltens
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

10.  Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration.

Authors:  Sandra Bell-McGinty; Meryl A Butters; Carolyn Cidis Meltzer; Phil J Greer; Charles F Reynolds; James T Becker
Journal:  Am J Psychiatry       Date:  2002-08       Impact factor: 18.112

View more
  34 in total

Review 1.  Cognitive functioning and late-life depression.

Authors:  Aaron M Koenig; Rishi K Bhalla; Meryl A Butters
Journal:  J Int Neuropsychol Soc       Date:  2014-03-31       Impact factor: 2.892

2.  Association of age at depression onset with cognitive functioning in individuals with late-life depression and executive dysfunction.

Authors:  R Scott Mackin; J Craig Nelson; Kevin L Delucchi; Patrick J Raue; Derek D Satre; Dimitris N Kiosses; George S Alexopoulos; Patricia A Arean
Journal:  Am J Geriatr Psychiatry       Date:  2014-02-26       Impact factor: 4.105

3.  Latent Classes of Cognitive Functioning Among Depressed Older Adults Without Dementia.

Authors:  Ruth T Morin; Philip Insel; Craig Nelson; Meryl Butters; David Bickford; Susan Landau; Andrew Saykin; Michael Weiner; R Scott Mackin
Journal:  J Int Neuropsychol Soc       Date:  2019-06-24       Impact factor: 2.892

4.  Vascular burden and cognitive functioning in depressed older adults.

Authors:  Brooke Schneider; Linda Ercoli; Prabha Siddarth; Helen Lavretsky
Journal:  Am J Geriatr Psychiatry       Date:  2012-08       Impact factor: 4.105

5.  Volumetric brain differences in clinical depression in association with anxiety: a systematic review with meta-analysis.

Authors:  Daniela A Espinoza Oyarce; Marnie E Shaw; Khawlah Alateeq; Nicolas Cherbuin
Journal:  J Psychiatry Neurosci       Date:  2020-11-01       Impact factor: 6.186

6.  Comparing the Immune-Genomic Effects of Vilazodone and Paroxetine in Late-Life Depression: A Pilot Study.

Authors:  Harris Eyre; Prabha Siddarth; Natalie Cyr; Hongyu Yang; Steve Cole; Malcolm Forbes; Helen Lavretsky
Journal:  Pharmacopsychiatry       Date:  2017-04-25       Impact factor: 5.788

7.  A longitudinal study of differences in late- and early-onset geriatric depression: depressive symptoms and psychosocial, cognitive, and neurological functioning.

Authors:  Natalie Sachs-Ericsson; Elizabeth Corsentino; Jerad Moxley; Jennifer L Hames; Nicole C Rushing; Kathryn Sawyer; Thomas Joiner; Edward A Selby; Steven Zarit; Ian H Gotlib; David C Steffens
Journal:  Aging Ment Health       Date:  2012-08-30       Impact factor: 3.658

8.  Organic bases of late-life depression: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2013-01-25       Impact factor: 3.575

9.  Effects of kaixin jieyu decoction on behavior and glial fibrillary acidic protein expression in cerebral hippocampus of a rat vascular depression model.

Authors:  Xian-hui Zhang; Shi-jing Huang; Yan-yun Wang; Ying Zhang; Ju-hua Pan; Jun Zheng; Duo-jiao Li; Xiao-ming Lei
Journal:  Chin J Integr Med       Date:  2014-08-06       Impact factor: 1.978

Review 10.  Pathways linking late-life depression to persistent cognitive impairment and dementia.

Authors:  Meryl A Butters; Jeffrey B Young; Oscar Lopez; Howard J Aizenstein; Benoit H Mulsant; Charles F Reynolds; Steven T DeKosky; James T Becker
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.